XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2020   94,483,136      
Balance at beginning of period at Dec. 31, 2020 $ 2,746,649 $ 931 $ 2,354,871 $ 330,555 $ 60,292
Increase (Decrease) in Stockholders' Equity          
Net income 68,668     68,668  
Other comprehensive loss (75,481)       (75,481)
Repurchase and retirement of common stock (in shares)   (199,674)      
Repurchase and retirement of common stock (6,897) $ (2) (4,977) (1,918)  
Cash dividends declared (28,287)     (28,287)  
Dividend equivalents declared 0   107 (107)  
Share-based compensation expense 3,105   3,105    
Issuance of restricted stock, net (in shares)   419,757      
Issuance of restricted stock, net 0 $ 2 (2)    
Restricted stock surrendered and canceled (in shares)   (100,550)      
Restricted stock surrendered and canceled (5,279)   (5,279)    
Exercise of stock options (in shares)   41,746      
Exercise of stock options 620   620    
Balance at end of period (in shares) at Mar. 31, 2021   94,644,415      
Balance at end of period at Mar. 31, 2021 $ 2,703,098 $ 931 2,348,445 368,911 (15,189)
Balance at beginning of period (in shares) at Dec. 31, 2021 94,389,543 94,389,543      
Balance at beginning of period at Dec. 31, 2021 $ 2,886,311 $ 929 2,351,294 541,950 (7,862)
Increase (Decrease) in Stockholders' Equity          
Net income 66,904     66,904  
Other comprehensive loss (136,371)       (136,371)
Cash dividends declared (31,142)     (31,142)  
Dividend equivalents declared 0   121 (121)  
Share-based compensation expense 5,530   5,530    
Issuance of restricted stock, net (in shares)   714,783      
Issuance of restricted stock, net 0 $ 4 (4)    
Restricted stock surrendered and canceled (in shares)   (175,219)      
Restricted stock surrendered and canceled (8,548)   (8,548)    
Exercise of stock options (in shares)   16,742      
Exercise of stock options $ 334   334    
Balance at end of period (in shares) at Mar. 31, 2022 94,945,849 94,945,849      
Balance at end of period at Mar. 31, 2022 $ 2,783,018 $ 933 $ 2,348,727 $ 577,591 $ (144,233)